Synthesis, Anticancer Evaluation and DNA‐Binding Spectroscopic Insights of Quinoline‐Based 1, 3, 4‐Oxadiazole‐1, 2, 3‐triazole Conjugates. Issue 41 (7th November 2019)
- Record Type:
- Journal Article
- Title:
- Synthesis, Anticancer Evaluation and DNA‐Binding Spectroscopic Insights of Quinoline‐Based 1, 3, 4‐Oxadiazole‐1, 2, 3‐triazole Conjugates. Issue 41 (7th November 2019)
- Main Title:
- Synthesis, Anticancer Evaluation and DNA‐Binding Spectroscopic Insights of Quinoline‐Based 1, 3, 4‐Oxadiazole‐1, 2, 3‐triazole Conjugates
- Authors:
- Shamsi, Farheen
Aneja, Babita
Hasan, Phool
Zeya, Bushra
Zafaryab, M
Mehdi, Syed Hassan
Rizvi, M. Moshahid Alam
Patel, Rajan
Rana, Sandeep
Abid, Mohammad - Abstract:
- Abstract: The present work involves a pharmacophore hybridization strategy to combine key biologically active scaffolds. The study led to the synthesis of quinoline based oxadiazole‐triazole conjugates with favorable physicochemical properties as anti‐cancer agents. Among the synthesized compounds 8(a–p), in vitro screening against a panel of four cancer cell lines identified compound 8k, with o ‐chloro substitution on the phenyl ring, as potent against human lung carcinoma (A‐549) cells (IC50 =5.6 μM), while showing no significant cytotoxicity upto 200 μM concentration in normal cells. Compound 8 k with o ‐chloro substitution induced nuclear morphological changes in A‐549 cells as visualized by DAPI (4, 6‐diamidino‐2‐phenylindole) and was shown to bind firmly with A−T rich region in DNA. Changes in DNA topology studied through gel electrophoresis and groove mode of binding to ct‐DNA through multi‐spectroscopic techniques were observed, further validated by molecular docking studies. Overall, the study illustrates successful hybridization strategy leading to compound 8 k as promising anticancer agent for further structural optimization and biological evaluation. Abstract : In silico ADME (Absorption, Distribution, Metabolism and Excretion) assessment demonstrated drug like properties of the synthesized quinoline based 1, 3, 4‐oxadiazole‐1, 2, 3‐triazole compounds. Out of 16 compounds, 8k with o ‐chloro substitution on phenyl ring, found to be active against A‐549 cells withAbstract: The present work involves a pharmacophore hybridization strategy to combine key biologically active scaffolds. The study led to the synthesis of quinoline based oxadiazole‐triazole conjugates with favorable physicochemical properties as anti‐cancer agents. Among the synthesized compounds 8(a–p), in vitro screening against a panel of four cancer cell lines identified compound 8k, with o ‐chloro substitution on the phenyl ring, as potent against human lung carcinoma (A‐549) cells (IC50 =5.6 μM), while showing no significant cytotoxicity upto 200 μM concentration in normal cells. Compound 8 k with o ‐chloro substitution induced nuclear morphological changes in A‐549 cells as visualized by DAPI (4, 6‐diamidino‐2‐phenylindole) and was shown to bind firmly with A−T rich region in DNA. Changes in DNA topology studied through gel electrophoresis and groove mode of binding to ct‐DNA through multi‐spectroscopic techniques were observed, further validated by molecular docking studies. Overall, the study illustrates successful hybridization strategy leading to compound 8 k as promising anticancer agent for further structural optimization and biological evaluation. Abstract : In silico ADME (Absorption, Distribution, Metabolism and Excretion) assessment demonstrated drug like properties of the synthesized quinoline based 1, 3, 4‐oxadiazole‐1, 2, 3‐triazole compounds. Out of 16 compounds, 8k with o ‐chloro substitution on phenyl ring, found to be active against A‐549 cells with an IC50 value of 5.6 μM. Nuclear morphological changes were observed by DAPI staining and photoactivated cleavage of pcDNA3.1 revealed changes in DNA topology induced by 8 k which was further validated through DNA binding studies by multi‐spectroscopic and molecular docking that showed binding of 8 k to minor groove of DNA. … (more)
- Is Part Of:
- ChemistrySelect. Volume 4:Issue 41(2019)
- Journal:
- ChemistrySelect
- Issue:
- Volume 4:Issue 41(2019)
- Issue Display:
- Volume 4, Issue 41 (2019)
- Year:
- 2019
- Volume:
- 4
- Issue:
- 41
- Issue Sort Value:
- 2019-0004-0041-0000
- Page Start:
- 12176
- Page End:
- 12182
- Publication Date:
- 2019-11-07
- Subjects:
- Anticancer inhibitors -- DNA-binding -- Drug-like properties -- Oxadiazole-Triazole -- Quinoline
Chemistry -- Periodicals
540.5 - Journal URLs:
- http://onlinelibrary.wiley.com/ ↗
http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2365-6549 ↗ - DOI:
- 10.1002/slct.201902797 ↗
- Languages:
- English
- ISSNs:
- 2365-6549
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3172.241000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 12126.xml